Cannabinoid treatment impacts adaptive behavior in autism patients and caregivers’ mental health: A prospective real-life cohort study
Progress in Brain Research · 2025 · 29-53
DOI: 10.1016/bs.pbr.2025.08.014 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Progress in Brain Research, 2025. Verfasst von Kelly Álvares Guimarães und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal dos Vales do Jequitinhonha e Mucuri - Campus JK, Diamantina, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Caregivers, Cannabidiol, Adaptation, Psychological, Autism Spectrum Disorder. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Pharmacological interventions for behavioral symptoms of Autism Spectrum Disorder (ASD) are limited and recent studies point out benefits with the use of cannabinoids. METHOD: This longitudinal observational study investigates ASD symptoms after 3 months of starting cannabidiol (CBD)-rich extract therapy and it's impact on the mental health of caregivers. Assessment was based on clinical and socioeconomic questionnaire, Autism Treatment Evaluation Checklist (ATEC), Childhood Autism Rating Scale (CARS) and Vineland 3 Scale. The Brief Symptom Inventory (BSI) was applied to evaluate caregiver's health. RESULTS: Sixteen patients with ASD who received cannabinoid treatment (CBD group) and seventeen patients with ASD without cannabinoid treatment (control group). CBD group was characterized as severe autism, ATEC total (SD) 85.5 ± 34.00, while controls as moderate, ATEC total (SD) 58.6 ± 25.53 (p = 0.047). After 3 months of treatment, CBD group showed a reduction in maladaptive behavior - internalizing (Vineland 3) (p = 0.008), and their caregivers a reduction in symptoms of Interpersonal Sensitivity (BSI) (p = 0.038), Global Severity Index (BSI) (p = 0.025) and Positive Symptom Distress Index (BSI) (p = 0.007), indicating reduction on mental health symptoms. For the control group, after 3 months there was a significant increase in scores for Daily Living Activities (Vineland 3) (p = 0.031) and Socialization (ATEC) (p = 0.037). CONCLUSION: This study suggests that therapy with cannabidiol (CBD)-rich extract in severe ASD may have positive effects on anxious and depressive symptoms, potentially positively impacting on the mental health of their caregivers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidade Federal dos Vales do Jequitinhonha e Mucuri - Campus JK, Diamantina, Minas Gerais, Brazil.
- Faculdade de Medicina de Diamantina (FAMED) da Universidade Federal dos Vales do Jequitinhonha e Mucuri - Campus JK, Diamantina, Minas Gerais, Brazil.
- Departamento de Medicina Interna, Centro de Ciências Médicas, Universidade Federal da Paraíba, João Pessoa, Paraíba, Brazil.
- Universidade Federal dos Vales do Jequitinhonha e Mucuri - Campus JK, Diamantina, Minas Gerais, Brazil. Electronic address: guilherme.nogueira@ufvjm.edu.br.
Zitieren
APA
Guimarães, K. Á., Jorge, L. P., Resende, A. L. O., da Silva Junior, E. A., Kummer, A. M. E., da Silva Lessa Júnior, W., & de Oliveira, G. N. M. (2025). Cannabinoid treatment impacts adaptive behavior in autism patients and caregivers’ mental health: A prospective real-life cohort study. Progress in Brain Research, 29-53. https://doi.org/10.1016/bs.pbr.2025.08.014
Vancouver
Guimarães KÁ, Jorge LP, Resende ALO, da Silva Junior EA, Kummer AME, da Silva Lessa Júnior W, et al. Cannabinoid treatment impacts adaptive behavior in autism patients and caregivers’ mental health: A prospective real-life cohort study. Progress in Brain Research. 2025:29-53. doi:10.1016/bs.pbr.2025.08.014
BibTeX
@article{Guimares2025,
author = {Guimarães, Kelly Álvares and Jorge, Letícia Perígolo and Resende, Ana Luiza de Oliveira and da Silva Junior, Estácio Amaro and Kummer, Arthur Melo E and da Silva Lessa Júnior, Wilson and de Oliveira, Guilherme Nogueira M},
title = {Cannabinoid treatment impacts adaptive behavior in autism patients and caregivers’ mental health: A prospective real-life cohort study},
journal = {Progress in Brain Research},
year = {2025},
pages = {29--53},
doi = {10.1016/bs.pbr.2025.08.014}
}
EUVIMED